Emergent BioSolutions to Participate in Upcoming Investor Conferences
Emergent BioSolutions (NYSE:EBS) announced that senior management will participate in several upcoming investor conferences in late May and early June 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Emergent BioSolutions (NYSE:EBS) announced that senior management will participate in several upcoming investor conferences in late May and early June 2026.
Events include Goldman Sachs leveraged finance and global healthcare conferences, the Benchmark Healthcare House Call Virtual Investor Conference, and the Jefferies Global Healthcare Conference with webcast presentations and options for one-on-one meetings.
Details
News Market Reaction – EBS
On May 20, the day this news came out, EBS closed 1.12% above the previous close.
Data tracked by StockTitan Argus for the May 20 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., May 20, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences:
- Goldman Sachs 11th Annual Leveraged Finance and Credit Conference, May 27-29
- Benchmark 6th Annual Healthcare House Call Virtual Investor Conference, May 28
- Jefferies Global Healthcare Conference, June 2-4
- June 3: presentation and webcast, 1:20-1:50 p.m. eastern time, register here.
- Goldman Sachs 47th Annual Global Healthcare Conference, June 8-10
- June 8: presentation and webcast, 2:00-3:00 p.m. eastern time, register here.
- June 8: presentation and webcast, 2:00-3:00 p.m. eastern time, register here.
Please contact a conference representative to request one-on-one meetings.
About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com
Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.